Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Lobbyists Continue Pressing Their Cases
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed. "One of the groups key to working any deal is the pharmaceutical industry, which has been quite active behind the scenes," National Public Radio reports. NPR interviewed former congressman Billy Tauzin, who is president of PhRMA, the drug industry"s lobbying group. Tauzin said he couldn"t predict whether health reform, which his group supports, would make the industry wealthier, but added, "we"ll do okay" (7/30).

House Democrats' Health Bill Would Tax Rich To Finance Insurance Expansion
House Democratic leaders Tuesday unveiled their bill to reform America"s health care system - and insure an additional 37 million Americans over the next 10 years - to the tune of more than $1 trillion, funded mostly through an up-to-5.4 percent surtax on income for the wealthiest Americans, The Washington Post reports.
News of the day
Individual Health Insurance Market Failing Consumers According To New Report
The individual health insurance market is not a viable option for the majority of uninsured adults, a new report from The Commonwealth Fund finds. Seventy-three percent of people who tried to buy insurance on their own in the last three years did not purchase a policy, primarily because premiums were too high. In addition, among adults with individual coverage or who tried to buy coverage in the past three years, 57 percent said it was very difficult or impossible to find coverage they could afford, 47 percent said it was very difficult or impossible to find a plan with the coverage they needed, and 36 percent were denied coverage or charged more because of a pre-existing condition, or had the condition excluded from their coverage.
Oncology

RCN Responds To NHS Confederation Warning On The Downturn, UK

Commenting on the publication of the NHS Confederation report Dealing with the downturn: the greatest ever leadership challenge for the NHS, Dr Peter Carter, Chief Executive & General Secretary of the Royal College of Nursing (RCN), said: "This report paints a particularly bleak picture for the NHS over the next couple of years, which is deeply concerning. During a downturn, health can suffer and the NHS must be fit to deal with this. We are in total agreement with the NHS Confederation that cutting staffing levels and training would only exacerbate problems in an already stretched health service. "In times of financial difficulty, the need for stringent evaluation to ensure all spending offers genuine value for money, and that funding intended for patient care does not get siphoned off elsewhere, is even more important. "Our recent Freedom of Information request revealed that ÷£350 million pounds a year is spent on management consultants, of which over ÷£273 million was not related to direct patient care. This could account for more than 10% of the NHS savings expected by the Government. Every individual Trust needs to ask themselves if they need to take on a management consultant for certain tasks." Royal College of Nursing


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009